Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa.

Holmes CB, Losina E, Walensky RP, Yazdanpanah Y, Freedberg KA.

Clin Infect Dis. 2003 Mar 1;36(5):652-62. Epub 2003 Feb 17. Review.

PMID:
12594648
2.

Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections.

Hung CC, Chang SC.

J Antimicrob Chemother. 2004 Nov;54(5):849-53. Epub 2004 Sep 29. Review.

PMID:
15456733
3.

Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.

Dankner WM, Lindsey JC, Levin MJ; Pediatric AIDS Clinical Trials Group Protocol Teams 051, 128, 138, 144, 152, 179, 190, 220, 240, 245, 254, 300 and 327.

Pediatr Infect Dis J. 2001 Jan;20(1):40-8.

PMID:
11176565
4.

Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA/National AIDS Plan guidelines, 2004 [correction].

Berenguer J, Laguna F, López-Aldeguer J, Moreno S, Arribas JR, Arrizabalaga J, Baraia J, Casado JL, Cosín J, Polo R, González-García J, Iribarren JA, Kindelán JM, López-Bernaldo de Quirós JC, López-Vélez R, Lorenzo JF, Lozano F, Mallolas J, Miró JM, Pulido F, Ribera E.

Enferm Infecc Microbiol Clin. 2004 Mar;22(3):160-76. Review. English, Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2004 Nov;22(5):271.

PMID:
14987537
5.

[Severe opportunistic infections in HIV-positive adults in sub-Saharan Africa].

Anglaret X.

Med Trop (Mars). 2006 Aug;66(4):343-5. French.

PMID:
16999042
6.

The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.

Nachman S, Gona P, Dankner W, Weinberg A, Yogev R, Gershon A, Rathore M, Read JS, Huang S, Elgie C, Hudgens K, Hughes W.

Pediatrics. 2005 Apr;115(4):e488-94. Epub 2005 Mar 16.

PMID:
15772172
7.

Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis.

Suthar AB, Vitoria MA, Nagata JM, Anglaret X, Mbori-Ngacha D, Sued O, Kaplan JE, Doherty MC.

Lancet HIV. 2015 Apr;2(4):e137-50. doi: 10.1016/S2352-3018(15)00005-3. Epub 2015 Mar 3. Review.

PMID:
26424674
8.

Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis.

Siedner MJ, Ng CK, Bassett IV, Katz IT, Bangsberg DR, Tsai AC.

Clin Infect Dis. 2015 Apr 1;60(7):1120-7. doi: 10.1093/cid/ciu1137. Epub 2014 Dec 16.

9.

Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d'Ivoire: impact of alternative methods of CD4 count modelling.

Deuffic-Burban S, Losina E, Wang B, Gabillard D, Messou E, Divi N, Freedberg KA, Anglaret X, Yazdanpanah Y.

Eur J Epidemiol. 2007;22(10):737-44. Epub 2007 Sep 8.

10.

AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.

Anglaret X, Minga A, Gabillard D, Ouassa T, Messou E, Morris B, Traore M, Coulibaly A, Freedberg KA, Lewden C, Ménan H, Abo Y, Dakoury-Dogbo N, Toure S, Seyler C; ANRS 12222 Morbidity/Mortality Study Group.

Clin Infect Dis. 2012 Mar 1;54(5):714-23. doi: 10.1093/cid/cir898. Epub 2012 Feb 4.

11.
12.

The cost-effectiveness of preventing AIDS-related opportunistic infections.

Freedberg KA, Scharfstein JA, Seage GR 3rd, Losina E, Weinstein MC, Craven DE, Paltiel AD.

JAMA. 1998 Jan 14;279(2):130-6. Erratum in: JAMA 1999 Jun 2;281(21):1989.

PMID:
9440663
13.

Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.

Nesheim SR, Kapogiannis BG, Soe MM, Sullivan KM, Abrams E, Farley J, Palumbo P, Koenig LJ, Bulterys M.

Pediatrics. 2007 Jul;120(1):100-9.

PMID:
17606567
14.

Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa.

Korenromp EL, Williams BG, de Vlas SJ, Gouws E, Gilks CF, Ghys PD, Nahlen BL.

Emerg Infect Dis. 2005 Sep;11(9):1410-9. Review.

15.

Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.

Kaplan JE, Hu DJ, Holmes KK, Jaffe HW, Masur H, De Cock KM.

Am J Trop Med Hyg. 1996 Jul;55(1):1-11. Review.

PMID:
8702012
16.

Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996-1997.

Binquet C, Chêne G, Jacqmin-Gadda H, Journot V, Savès M, Lacoste D, Dabis F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

Am J Epidemiol. 2001 Feb 15;153(4):386-93.

PMID:
11207157
17.

Co-trimoxazole, cART, and non-AIDS infectious diseases.

Anglaret X, Eholie S.

Lancet. 2010 Apr 10;375(9722):1231-3. doi: 10.1016/S0140-6736(10)60200-0. Epub 2010 Mar 27. No abstract available.

PMID:
20347482
18.

HIV and co-infections.

Chang CC, Crane M, Zhou J, Mina M, Post JJ, Cameron BA, Lloyd AR, Jaworowski A, French MA, Lewin SR.

Immunol Rev. 2013 Jul;254(1):114-42. doi: 10.1111/imr.12063. Review.

19.
20.

Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival.

Staehelin C, Rickenbach M, Low N, Egger M, Ledergerber B, Hirschel B, D'Acremont V, Battegay M, Wagels T, Bernasconi E, Kopp C, Furrer H; Swiss HIV Cohort Study.

AIDS. 2003 Oct 17;17(15):2237-44.

PMID:
14523281

Supplemental Content

Support Center